According to Paolo Ardoino, Atai Life Sciences and Christian Angermayer have made a strategic decision to incorporate Bitcoin into their balance sheet. This move is seen as a reinforcement of the company's financial fundamentals. By holding Bitcoin, the company aims to leverage its potential as a store of value and hedge against inflation, which is relevant for trading strategies and long-term financial planning (source: @paoloardoino).